person · Reporting owner

SMITH MICHAEL L

Disclosed activity across 5 companies

Tapewire entity: 126798
SEC CIK: 0001194201

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
First Internet BancorpINBK · Entity 6166	Director	January 18, 2021	January 20, 2021
agilon health, inc.AGL · Entity 4698	Director	May 25, 2022	May 27, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

First Internet Bancorp

Report date January 18, 2021 · Filed January 20, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	3,273	Reported balance After 2021-01-18 transaction · row 1 1 source row Row 1 · 2021-01-18 · Grant · Acquired 1,810 · Balance 3,273 F1: Restricted stock award scheduled to vest as follows: 149 shares were fully vested on the date of grant and 151 shares will vest on the fifteenth day of each month beginning February 15, 2021 and ending on December 15, 2021.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock award scheduled to vest as follows: 149 shares were fully vested on the date of grant and 151 shares will vest on the fifteenth day of each month beginning February 15, 2021 and ending on December 15, 2021.

agilon health, inc.

Report date May 25, 2022 · Filed May 27, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy trust	4,126	Reported balance After 2022-05-25 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2022-05-25 · Sale · Disposed 145,874 · Balance 4,126 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.500095 to $19.803329, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: These shares of common stock are held in the Michael L. Smith Revised and Amended Trust Dated August 1, 2011.
Common StockSEC Table I · non-derivative	Direct	158,992	Reported balance Holding disclosure · report date 2022-05-25 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 158,992 F3: Includes restricted stock units.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.500095 to $19.803329, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2: These shares of common stock are held in the Michael L. Smith Revised and Amended Trust Dated August 1, 2011.

F3: Includes restricted stock units.

Past disclosures · reporting ended (3)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Envision Healthcare Corp

Report date August 07, 2018 · Filed October 15, 2018

Section 16 reporting ended · disclosed 2018-10-15. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Ending reported balance After 2018-10-11 transaction · row 3 2 source rows · reconciled sequence Row 1 · 2018-08-07 · Gift · Disposed 1,503 · Balance 15,490 F1: Shares gifted to charity. Row 3 · 2018-10-11 · Disposition to issuer · Disposed 15,490 · Balance 0 F2: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes. F3: Includes 15,490 restricted stock unit awards ("Company RSUs"). At the Effective Time, each Company RSU that was outstanding as of immediately prior to the Effective Time was converted into the right to receive an amount in cash equal to the sum of (i) the product of (A) the total number of shares of Company Common Stock subject to such Company RSU immediately prior to the Effective Time and (B) the Merger Consideration and (ii) any accrued but unpaid dividend equivalents with respect to such Company RSU.
Common StockSEC Table I · non-derivative	IndirectBy Trust	0	Reported balance After 2018-08-07 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2018-08-07 · Gift · Disposed 9,248 · Balance 0 F1: Shares gifted to charity.

Filing footnotes · ownership attribution and instrument terms

F1: Shares gifted to charity.

F2: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes.

F3: Includes 15,490 restricted stock unit awards ("Company RSUs"). At the Effective Time, each Company RSU that was outstanding as of immediately prior to the Effective Time was converted into the right to receive an amount in cash equal to the sum of (i) the product of (A) the total number of shares of Company Common Stock subject to such Company RSU immediately prior to the Effective Time and (B) the Merger Consideration and (ii) any accrued but unpaid dividend equivalents with respect to such Company RSU.

Envision Healthcare Holdings, Inc.

Report date December 01, 2016 · Filed December 01, 2016

Section 16 reporting ended · disclosed 2016-12-01. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2016-12-01 transaction · row 1 1 source row Row 1 · 2016-12-01 · Disposition to issuer · Disposed 29,506 · Balance 0 F1: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F2: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each deferred stock unit held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst deferred stock unit having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).
Common StockSEC Table I · non-derivative	IndirectBy Trust	0	Reported balance After 2016-12-01 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2016-12-01 · Disposition to issuer · Disposed 27,689 · Balance 0 F1: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F3: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each share of common stock held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). F4: These shares of common stock are held in the Michael L. Smith 2013 GRAT I.

Filing footnotes · ownership attribution and instrument terms

F1: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3.

F2: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each deferred stock unit held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst deferred stock unit having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).

F3: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each share of common stock held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).

F4: These shares of common stock are held in the Michael L. Smith 2013 GRAT I.

VECTREN CORP

Report date February 01, 2019 · Filed February 01, 2019

Section 16 reporting ended · disclosed 2019-02-01. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Ending reported balance After 2019-02-01 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2019-02-01 · Exercise / conversion · Acquired 126.174 · Balance 126.174 F1: Pursuant to the Agreement and Plan of Merger by and among Vectren Corporation, CenterPoint Energy, Inc., and Pacer Merger Sub, Inc. dated April 21, 2018 (the 'Merger Agreement'), represents stock units granted effective January 1, 2019 subject to one-year time vesting, which have been pro-rated through the Effective Time. Each stock unit was cancelled and converted into the right to receive $72.00 in cash at the Effective Time. The time when Pacer Merger Sub, Inc. effectively merged with and into Vectren Corporation is referred to as the 'Effective Time.' Row 2 · 2019-02-01 · Disposition to issuer · Disposed 126.174 · Balance 0 F2: Represents the cancellation and conversion of the stock units noted in footnote (1) into the right to receive $72.00 in cash at the Effective Time pursuant to the terms of the Merger Agreement.
Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2019-02-01 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2019-02-01 · Disposition to issuer · Disposed 16,921.3883 · Balance 0 F3: Represents phantom stock units held in a book-entry under the non-qualified deferred compensation plan. Each phantom stock unit was deemed to be cancelled and converted into the right to receive $72.00 in cash at the Effective Time pursuant to the terms of the Merger Agreement.
Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2019-02-01 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2019-02-01 · Exercise / conversion · Disposed 126.174 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger by and among Vectren Corporation, CenterPoint Energy, Inc., and Pacer Merger Sub, Inc. dated April 21, 2018 (the 'Merger Agreement'), represents stock units granted effective January 1, 2019 subject to one-year time vesting, which have been pro-rated through the Effective Time. Each stock unit was cancelled and converted into the right to receive $72.00 in cash at the Effective Time. The time when Pacer Merger Sub, Inc. effectively merged with and into Vectren Corporation is referred to as the 'Effective Time.'

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger by and among Vectren Corporation, CenterPoint Energy, Inc., and Pacer Merger Sub, Inc. dated April 21, 2018 (the 'Merger Agreement'), represents stock units granted effective January 1, 2019 subject to one-year time vesting, which have been pro-rated through the Effective Time. Each stock unit was cancelled and converted into the right to receive $72.00 in cash at the Effective Time. The time when Pacer Merger Sub, Inc. effectively merged with and into Vectren Corporation is referred to as the 'Effective Time.'

F2: Represents the cancellation and conversion of the stock units noted in footnote (1) into the right to receive $72.00 in cash at the Effective Time pursuant to the terms of the Merger Agreement.

F3: Represents phantom stock units held in a book-entry under the non-qualified deferred compensation plan. Each phantom stock unit was deemed to be cancelled and converted into the right to receive $72.00 in cash at the Effective Time pursuant to the terms of the Merger Agreement.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 25, 2022 Filed May 27, 2022 16:04 UTC	agilon health, inc. AGL · Entity 4698	SaleCommon Stock	145,874	$19.53	$2,849,458.95	Disclosure SEC source: 0001209191-22-032487 · doc4.xml · nonDerivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 4,126 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.500095 to $19.803329, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: These shares of common stock are held in the Michael L. Smith Revised and Amended Trust Dated August 1, 2011. Read SEC document
April 14, 2022 Filed Apr 20, 2022 16:58 UTC	agilon health, inc. AGL · Entity 4698	GrantCommon Stock	6,936	$0.00	$0.00	Disclosure SEC source: 0001209191-22-025021 · doc4.xml · nonDerivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,992 F1 · shares: Restricted stock units that vest in full on April 14, 2023, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document
April 14, 2021 Filed Apr 16, 2021 19:05 UTC	agilon health, inc. AGL · Entity 4698	GrantCommon Stock	6,956	$0.00	$0.00	Disclosure SEC source: 0001209191-21-027046 · doc4.xml · nonDerivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,056 F1 · shares: Restricted stock units that vests in full on April 14, 2022, subject to continued service as a director. Read SEC document
January 18, 2021 Filed Jan 20, 2021 16:09 UTC	First Internet Bancorp INBK · Entity 6166	GrantCommon Stock	1,810	$0.00	$0.00	Disclosure SEC source: 0001562463-21-000023 · wf-form4_161117694205235.xml · nonDerivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,273 F1 · shares: Restricted stock award scheduled to vest as follows: 149 shares were fully vested on the date of grant and 151 shares will vest on the fifteenth day of each month beginning February 15, 2021 and ending on December 15, 2021. Read SEC document
June 03, 2020 Filed Jun 5, 2020 09:50 UTC	First Internet Bancorp INBK · Entity 6166	GrantCommon Stock	1,463	$0.00	$0.00	Disclosure SEC source: 0001562463-20-000068 · wf-form4_159136500578726.xml · nonDerivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,463 F1 · shares: Restricted stock award scheduled to vest as follows: 189 shares were fully vested on the date of grant and 182 shares will vest on the fifteenth day of each month beginning June 15, 2020 and ending on December 15, 2020. Read SEC document
February 01, 2019 Filed Feb 1, 2019 09:22 UTC	VECTREN CORP VVC · Entity 160701	Exercise / conversionPhantom Stock · Derivative	126.174	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0001562180-19-000623 · primarydocument.xml · derivative · entry 4 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 126.174 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Pursuant to the Agreement and Plan of Merger by and among Vectren Corporation, CenterPoint Energy, Inc., and Pacer Merger Sub, Inc. dated April 21, 2018 (the 'Merger Agreement'), represents stock units granted effective January 1, 2019 subject to one-year time vesting, which have been pro-rated through the Effective Time. Each stock unit was cancelled and converted into the right to receive $72.00 in cash at the Effective Time. The time when Pacer Merger Sub, Inc. effectively merged with and into Vectren Corporation is referred to as the 'Effective Time.' F1 · derivative.exercise_date: Pursuant to the Agreement and Plan of Merger by and among Vectren Corporation, CenterPoint Energy, Inc., and Pacer Merger Sub, Inc. dated April 21, 2018 (the 'Merger Agreement'), represents stock units granted effective January 1, 2019 subject to one-year time vesting, which have been pro-rated through the Effective Time. Each stock unit was cancelled and converted into the right to receive $72.00 in cash at the Effective Time. The time when Pacer Merger Sub, Inc. effectively merged with and into Vectren Corporation is referred to as the 'Effective Time.' F1 · derivative.expiration_date: Pursuant to the Agreement and Plan of Merger by and among Vectren Corporation, CenterPoint Energy, Inc., and Pacer Merger Sub, Inc. dated April 21, 2018 (the 'Merger Agreement'), represents stock units granted effective January 1, 2019 subject to one-year time vesting, which have been pro-rated through the Effective Time. Each stock unit was cancelled and converted into the right to receive $72.00 in cash at the Effective Time. The time when Pacer Merger Sub, Inc. effectively merged with and into Vectren Corporation is referred to as the 'Effective Time.' Read SEC document
February 01, 2019 Filed Feb 1, 2019 09:22 UTC	VECTREN CORP VVC · Entity 160701	Disposition to issuerPhantom Stock · Derivative	16,921.3883	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0001562180-19-000623 · primarydocument.xml · derivative · entry 3 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,921.3883 shares Expires not disclosed F3 · price: Represents phantom stock units held in a book-entry under the non-qualified deferred compensation plan. Each phantom stock unit was deemed to be cancelled and converted into the right to receive $72.00 in cash at the Effective Time pursuant to the terms of the Merger Agreement. F3 · derivative.exercise_date: Represents phantom stock units held in a book-entry under the non-qualified deferred compensation plan. Each phantom stock unit was deemed to be cancelled and converted into the right to receive $72.00 in cash at the Effective Time pursuant to the terms of the Merger Agreement. F3 · derivative.expiration_date: Represents phantom stock units held in a book-entry under the non-qualified deferred compensation plan. Each phantom stock unit was deemed to be cancelled and converted into the right to receive $72.00 in cash at the Effective Time pursuant to the terms of the Merger Agreement. Read SEC document
February 01, 2019 Filed Feb 1, 2019 09:22 UTC	VECTREN CORP VVC · Entity 160701	Disposition to issuerCommon Stock	126.174	Not disclosed	Not disclosed	Disclosure SEC source: 0001562180-19-000623 · primarydocument.xml · nonDerivative · entry 2 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Represents the cancellation and conversion of the stock units noted in footnote (1) into the right to receive $72.00 in cash at the Effective Time pursuant to the terms of the Merger Agreement. Read SEC document
February 01, 2019 Filed Feb 1, 2019 09:22 UTC	VECTREN CORP VVC · Entity 160701	Exercise / conversionCommon Stock	126.174	Not disclosed	Not disclosed	Disclosure SEC source: 0001562180-19-000623 · primarydocument.xml · nonDerivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126.174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Pursuant to the Agreement and Plan of Merger by and among Vectren Corporation, CenterPoint Energy, Inc., and Pacer Merger Sub, Inc. dated April 21, 2018 (the 'Merger Agreement'), represents stock units granted effective January 1, 2019 subject to one-year time vesting, which have been pro-rated through the Effective Time. Each stock unit was cancelled and converted into the right to receive $72.00 in cash at the Effective Time. The time when Pacer Merger Sub, Inc. effectively merged with and into Vectren Corporation is referred to as the 'Effective Time.' Read SEC document
January 01, 2019 Filed Jan 2, 2019 16:57 UTC	VECTREN CORP VVC · Entity 160701	GrantPhantom Stock · Derivative	1,582	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001562180-19-000078 · primarydocument.xml · derivative · entry 3 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,682.3883 Underlying: Common Stock · 1,582 shares Expires not disclosed F3 · kind: The reporting person elected to defer the stock unit award to the phantom stock account of the Vectren Corporation Nonqualified Deferred Compensation Plan. This transaction is exempt under Section 16b-3. F4 · derivative.exercise_date: Phantom stock units held under the non-qualified deferred compensation plan will effectively be exercised at the time amounts represented by those units are paid out under the Plan. Generally, unless provided otherwise by the participant, the payout begins with the end of the board member's service as a member of the board. Pursuant to the non-qualified deferred compensation plan, payouts can occur for up to 15 years. Amounts held in the phantom stock accounts would be amortized over that period unless directed otherwise by the participant. F4 · derivative.expiration_date: Phantom stock units held under the non-qualified deferred compensation plan will effectively be exercised at the time amounts represented by those units are paid out under the Plan. Generally, unless provided otherwise by the participant, the payout begins with the end of the board member's service as a member of the board. Pursuant to the non-qualified deferred compensation plan, payouts can occur for up to 15 years. Amounts held in the phantom stock accounts would be amortized over that period unless directed otherwise by the participant. Read SEC document
January 01, 2019 Filed Jan 2, 2019 16:57 UTC	VECTREN CORP VVC · Entity 160701	Exercise / conversionPhantom Stock · Derivative	1,582	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001562180-19-000078 · primarydocument.xml · derivative · entry 2 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,582 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock unit award was granted pursuant to the Vectren Corporation At Risk Compensation Plan (Plan) and was subject to the terms, provisions and conditions of the Plan and Plan grant agreement. The lifting of restrictions and forfeiture provisions were dependent upon continued service by the grantee until January 1, 2019, except as described in the Plan and the Plan grant agreement. The grantee was paid for each stock unit, in cash, the value of one share of Vectren's common stock on the date restrictions lapsed. The conditions associated with the award have been fulfilled and it has now been settled. This transaction was approved in accordance with Rule 16b-3. F2 · derivative.expiration_date: The stock unit award was granted pursuant to the Vectren Corporation At Risk Compensation Plan (Plan) and was subject to the terms, provisions and conditions of the Plan and Plan grant agreement. The lifting of restrictions and forfeiture provisions were dependent upon continued service by the grantee until January 1, 2019, except as described in the Plan and the Plan grant agreement. The grantee was paid for each stock unit, in cash, the value of one share of Vectren's common stock on the date restrictions lapsed. The conditions associated with the award have been fulfilled and it has now been settled. This transaction was approved in accordance with Rule 16b-3. Read SEC document
January 01, 2019 Filed Jan 2, 2019 15:13 UTC	VECTREN CORP VVC · Entity 160701	GrantPhantom Stock · Derivative	1,431	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001562180-19-000036 · primarydocument.xml · derivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,431 Underlying: Common Stock · 1,431 shares Expires not disclosed F1 · derivative.exercise_date: The stock unit award was granted pursuant to the Vectren Corporation At Risk Compensation Plan (Plan) and is subject to the terms, provisions and conditions of the Plan and Plan grant agreement. The lifting of restrictions and forfeiture provisions are dependent upon continued service by the grantee until January 1, 2020, except as described in the Plan and the Plan grant agreement. If the service of the grantee ends at the annual shareholder meeting, the stock unit award will vest at such time and will be prorated based upon the number of days served. F2 · derivative.exercise_date: The grantee will be paid for each stock unit, in cash, the value of one share of Vectren's common stock on the date restrictions lapse, provided grantee is in compliance with the share ownership guidelines established by the company. If the grantee is not then in compliance with the company's share ownership guidelines, the value of each stock unit will be paid to the grantee in one unrestricted share of Vectren's common stock. This acquisition was approved in accordance with Rule 16b-3. F3 · derivative.exercise_date: If the closing date of the previously announced merger transaction between Vectren Corporation and CenterPoint Energy, Inc. (CNP) occurs prior to January 1, 2020, then the Stock Unit Awards shall be cancelled and converted into a vested right to receive cash in an amount equal to (i) $72.00 multiplied by (ii) the number of Stock Unit Awards provided hereunder multiplied by (iii) a fraction with a numerator equal to the number of days in the period beginning on the Grant Date and ending on the closing date of the transaction with CNP and a denominator equal to 365, but in no event shall such fraction be greater than one. F1 · derivative.expiration_date: The stock unit award was granted pursuant to the Vectren Corporation At Risk Compensation Plan (Plan) and is subject to the terms, provisions and conditions of the Plan and Plan grant agreement. The lifting of restrictions and forfeiture provisions are dependent upon continued service by the grantee until January 1, 2020, except as described in the Plan and the Plan grant agreement. If the service of the grantee ends at the annual shareholder meeting, the stock unit award will vest at such time and will be prorated based upon the number of days served. F2 · derivative.expiration_date: The grantee will be paid for each stock unit, in cash, the value of one share of Vectren's common stock on the date restrictions lapse, provided grantee is in compliance with the share ownership guidelines established by the company. If the grantee is not then in compliance with the company's share ownership guidelines, the value of each stock unit will be paid to the grantee in one unrestricted share of Vectren's common stock. This acquisition was approved in accordance with Rule 16b-3. F3 · derivative.expiration_date: If the closing date of the previously announced merger transaction between Vectren Corporation and CenterPoint Energy, Inc. (CNP) occurs prior to January 1, 2020, then the Stock Unit Awards shall be cancelled and converted into a vested right to receive cash in an amount equal to (i) $72.00 multiplied by (ii) the number of Stock Unit Awards provided hereunder multiplied by (iii) a fraction with a numerator equal to the number of days in the period beginning on the Grant Date and ending on the closing date of the transaction with CNP and a denominator equal to 365, but in no event shall such fraction be greater than one. Read SEC document
January 01, 2019 Filed Jan 9, 2019 10:27 UTC	VECTREN CORP VVC · Entity 160701	OtherPhantom Stock · Derivative	1,761	$71.98 Strike: $0.00	$126,756.78	Disclosure SEC source: 0001562180-19-000241 · primarydocument.xml · derivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,921.3883 Underlying: Common Stock · 1,761 shares Expires not disclosed F1 · kind: The reporting person received an optional scheduled distribution from the Vectren Corporation Nonqualified Deferred Compensation Plan pursuant to the terms of the Plan. The distribution elections were made during open enrollment for the 2012 Plan year. This discretionary transaction is exempt under Rule 16b-3(b)(f). Each share of phantom stock was the equivalent of one share of Vectren common stock. Pursuant to the terms of the Plan, the phantom shares were payable in cash to the reporting person within 60 days of the scheduled distribution date. F2 · derivative.exercise_date: Phantom stock units held under the non-qualified deferred compensation plan will effectively be exercised at the time amounts represented by those units are paid out under the Plan. Generally, unless provided otherwise by the participant, the payout begins with the end of the board member's service as a member of the board. Pursuant to the non-qualified deferred compensation plan, payouts can occur for up to 15 years. Amounts held in the phantom stock accounts would be amortized over that period unless directed otherwise by the participant. F2 · derivative.expiration_date: Phantom stock units held under the non-qualified deferred compensation plan will effectively be exercised at the time amounts represented by those units are paid out under the Plan. Generally, unless provided otherwise by the participant, the payout begins with the end of the board member's service as a member of the board. Pursuant to the non-qualified deferred compensation plan, payouts can occur for up to 15 years. Amounts held in the phantom stock accounts would be amortized over that period unless directed otherwise by the participant. Read SEC document
October 11, 2018 Filed Oct 15, 2018 12:56 UTC	Envision Healthcare Corp EVHC · Entity 162981	Disposition to issuerCommon Stock	15,490	$46.00	$712,540.00	Disclosure SEC source: 0001678531-18-000155 · wf-form4_153962256613473.xml · nonDerivative · entry 3 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · shares: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes. F3 · shares: Includes 15,490 restricted stock unit awards ("Company RSUs"). At the Effective Time, each Company RSU that was outstanding as of immediately prior to the Effective Time was converted into the right to receive an amount in cash equal to the sum of (i) the product of (A) the total number of shares of Company Common Stock subject to such Company RSU immediately prior to the Effective Time and (B) the Merger Consideration and (ii) any accrued but unpaid dividend equivalents with respect to such Company RSU. F2 · price: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes. Read SEC document
August 07, 2018 Filed Oct 15, 2018 12:56 UTC	Envision Healthcare Corp EVHC · Entity 162981	GiftCommon Stock	9,248	Not disclosed	Not disclosed	Disclosure SEC source: 0001678531-18-000155 · wf-form4_153962256613473.xml · nonDerivative · entry 2 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 F1 · shares: Shares gifted to charity. F1 · price: Shares gifted to charity. Read SEC document
August 07, 2018 Filed Oct 15, 2018 12:56 UTC	Envision Healthcare Corp EVHC · Entity 162981	GiftCommon Stock	1,503	Not disclosed	Not disclosed	Disclosure SEC source: 0001678531-18-000155 · wf-form4_153962256613473.xml · nonDerivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,490 F1 · shares: Shares gifted to charity. F1 · price: Shares gifted to charity. Read SEC document
July 26, 2018 Filed Jan 2, 2019 16:57 UTC	VECTREN CORP VVC · Entity 160701	GiftCommon Stock	2,184	$0.00	$0.00	Disclosure SEC source: 0001562180-19-000078 · primarydocument.xml · nonDerivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: A "bona fide" gift of securities to charitable organizations is exempt under Section 16(b) by virtue of Rule 16(b)-5. Read SEC document
May 25, 2018 Filed May 29, 2018 18:20 UTC	Envision Healthcare Corp EVHC · Entity 162981	GrantCommon Stock	4,017	$43.57	$175,020.69	Disclosure SEC source: 0001678531-18-000087 · wf-form4_152763241114052.xml · nonDerivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,993 F1 · kind: Represents deferred stock units granted, pursuant to the Reporting Person's election, in lieu of the annual restricted stock unit award to non-employee directors for service on the Company's board of directors (the "Board"). The deferred stock units vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Company's next annual shareholders meeting, in each case subject to continued service on the Board. Pursuant to the Reporting Person's election, once vested the settlement of these deferred stock units will be deferred until the earlier of the Reporting Person's termination of board service and a change in control of the Company. Read SEC document
January 01, 2018 Filed Jan 2, 2018 15:41 UTC	VECTREN CORP VVC · Entity 160701	GrantPhantom Stock · Derivative	1,582	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001562180-18-000045 · primarydocument.xml · derivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,582 Underlying: Common Stock · 1,582 shares Expires not disclosed F1 · derivative.exercise_date: The stock unit award was granted pursuant to the Vectren Corporation At Risk Compensation Plan (Plan) and is subject to the terms, provisions and conditions of the Plan and Plan grant agreement. The lifting of restrictions and forfeiture provisions are dependent upon continued service by the grantee until January 1, 2019, except as described in the Plan and the Plan grant agreement. If the service of the grantee ends at the annual shareholder meeting, the stock unit award will vest at such time and will be prorated based upon the number of days served. F2 · derivative.exercise_date: The grantee will be paid for each stock unit, in cash, the value of one share of Vectren's common stock on the date restrictions lapse, provided grantee is in compliance with the share ownership guidelines established by the company. If the grantee is not then in compliance with the company's share ownership guidelines, the value of each stock unit will be paid to the grantee in one unrestricted share of Vectren's common stock. This acquisition was approved in accordance with Rule 16b-3. F1 · derivative.expiration_date: The stock unit award was granted pursuant to the Vectren Corporation At Risk Compensation Plan (Plan) and is subject to the terms, provisions and conditions of the Plan and Plan grant agreement. The lifting of restrictions and forfeiture provisions are dependent upon continued service by the grantee until January 1, 2019, except as described in the Plan and the Plan grant agreement. If the service of the grantee ends at the annual shareholder meeting, the stock unit award will vest at such time and will be prorated based upon the number of days served. F2 · derivative.expiration_date: The grantee will be paid for each stock unit, in cash, the value of one share of Vectren's common stock on the date restrictions lapse, provided grantee is in compliance with the share ownership guidelines established by the company. If the grantee is not then in compliance with the company's share ownership guidelines, the value of each stock unit will be paid to the grantee in one unrestricted share of Vectren's common stock. This acquisition was approved in accordance with Rule 16b-3. Read SEC document
January 01, 2018 Filed Jan 3, 2018 11:15 UTC	VECTREN CORP VVC · Entity 160701	GrantPhantom Stock · Derivative	1,860	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001562180-18-000101 · primarydocument.xml · derivative · entry 2 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,876.3883 Underlying: Common Stock · 1,860 shares Expires not disclosed F2 · kind: The reporting person elected to defer the stock unit award to the phantom stock account of the Vectren Corporation Nonqualified Deferred Compensation Plan. This transaction is exempt under Section 16b-3. F3 · derivative.exercise_date: Phantom stock units held under the non-qualified deferred compensation plan will effectively be exercised at the time amounts represented by those units are paid out under the Plan. Generally, unless provided otherwise by the participant, the payout begins with the end of the board member's service as a member of the board. Pursuant to the non-qualified deferred compensation plan, payouts can occur for up to 15 years. Amounts held in the phantom stock accounts would be amortized over that period unless directed otherwise by the participant. F3 · derivative.expiration_date: Phantom stock units held under the non-qualified deferred compensation plan will effectively be exercised at the time amounts represented by those units are paid out under the Plan. Generally, unless provided otherwise by the participant, the payout begins with the end of the board member's service as a member of the board. Pursuant to the non-qualified deferred compensation plan, payouts can occur for up to 15 years. Amounts held in the phantom stock accounts would be amortized over that period unless directed otherwise by the participant. Read SEC document
January 01, 2018 Filed Jan 3, 2018 11:15 UTC	VECTREN CORP VVC · Entity 160701	Exercise / conversionPhantom Stock · Derivative	1,860	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001562180-18-000101 · primarydocument.xml · derivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,860 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock unit award was granted pursuant to the Vectren Corporation At Risk Compensation Plan (Plan) and was subject to the terms, provisions and conditions of the Plan and Plan grant agreement. The lifting of restrictions and forfeiture provisions were dependent upon continued service by the grantee until January 1, 2018, except as described in the Plan and the Plan grant agreement. The grantee was paid for each stock unit, in cash, the value of one share of Vectren's common stock on the date restrictions lapsed. The conditions associated with the award have been fulfilled and it has now been settled. This transaction was approved in accordance with Rule 16b-3. F1 · derivative.expiration_date: The stock unit award was granted pursuant to the Vectren Corporation At Risk Compensation Plan (Plan) and was subject to the terms, provisions and conditions of the Plan and Plan grant agreement. The lifting of restrictions and forfeiture provisions were dependent upon continued service by the grantee until January 1, 2018, except as described in the Plan and the Plan grant agreement. The grantee was paid for each stock unit, in cash, the value of one share of Vectren's common stock on the date restrictions lapsed. The conditions associated with the award have been fulfilled and it has now been settled. This transaction was approved in accordance with Rule 16b-3. Read SEC document
January 01, 2018 Filed Jan 8, 2018 11:04 UTC	VECTREN CORP VVC · Entity 160701	OtherPhantom Stock · Derivative	3,776	$65.02 Strike: $0.00	$245,515.52	Disclosure SEC source: 0001562180-18-000250 · primarydocument.xml · derivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,100.3883 Underlying: Common Stock · 3,776 shares Expires not disclosed F1 · kind: The reporting person received an optional scheduled distribution from the Vectren Corporation Nonqualified Deferred Compensation Plan pursuant to the terms of the Plan. The distribution elections were made during open enrollment for the 2011 and the 2013 Plan year. This discretionary transaction is exempt under Rule 16b-3(b)(f). Each share of phantom stock was the equivalent of one share of Vectren common stock. Pursuant to the terms of the Plan, the phantom shares were payable in cash to the reporting person within 60 days of the scheduled distribution date. F2 · derivative.exercise_date: Phantom stock units held under the non-qualified deferred compensation plan will effectively be exercised at the time amounts represented by those units are paid out under the Plan. Generally, unless provided otherwise by the participant, the payout begins with the end of the board member's service as a member of the board. Pursuant to the non-qualified deferred compensation plan, payouts can occur for up to 15 years. Amounts held in the phantom stock accounts would be amortized over that period unless directed otherwise by the participant. F2 · derivative.expiration_date: Phantom stock units held under the non-qualified deferred compensation plan will effectively be exercised at the time amounts represented by those units are paid out under the Plan. Generally, unless provided otherwise by the participant, the payout begins with the end of the board member's service as a member of the board. Pursuant to the non-qualified deferred compensation plan, payouts can occur for up to 15 years. Amounts held in the phantom stock accounts would be amortized over that period unless directed otherwise by the participant. Read SEC document
May 25, 2017 Filed May 30, 2017 19:40 UTC	Envision Healthcare Corp EVHC · Entity 162981	GrantCommon Stock	3,124	$56.03	$175,037.72	Disclosure SEC source: 0001678531-17-000137 · wf-form4_149618759563776.xml · nonDerivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,976 F1 · kind: Represents deferred stock units granted, pursuant to the Reporting Person's election, in lieu of the annual restricted stock unit award to non-employee directors for service on the Company's board of directors (the "Board"). The deferred stock units vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Company's next annual shareholders meeting, in each case subject to continued service on the Board. Pursuant to the Reporting Person's election, once vested the settlement of these deferred stock units will be deferred until the earlier of the Reporting Person's termination of board service and a change in control of the Company. F2 · balance_after: The number of shares of common stock reported as beneficially owned by the reporting person has been reduced in order to correct a clerical error in the previous Form 4 filing. All reportable transactions have been previously reported. Read SEC document
January 01, 2017 Filed Jan 3, 2017 10:20 UTC	VECTREN CORP VVC · Entity 160701	GrantPhantom Stock · Derivative	1,860	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001562180-17-000030 · primarydocument.xml · derivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,860 Underlying: Common Stock · 1,860 shares Expires not disclosed F1 · derivative.exercise_date: The stock unit award was granted pursuant to the Vectren Corporation At Risk Compensation Plan (Plan) and is subject to the terms, provisions and conditions of the Plan and Plan grant agreement. The lifting of restrictions and forfeiture provisions are dependent upon continued service by the grantee until January 1, 2018, except as described in the Plan and the Plan grant agreement. If the service of the grantee ends at the annual shareholder meeting, the stock unit award will vest at such time and will be prorated based upon the number of days served. F2 · derivative.exercise_date: The grantee will be paid for each stock unit, in cash, the value of one share of Vectren's common stock on the date restrictions lapse, provided grantee is in compliance with the share ownership guidelines established by the company. If the grantee is not then in compliance with the company's share ownership guidelines, the value of each stock unit will be paid to the grantee in one unrestricted share of Vectren's common stock. This acquisition was approved in accordance with Rule 16b-3. F1 · derivative.expiration_date: The stock unit award was granted pursuant to the Vectren Corporation At Risk Compensation Plan (Plan) and is subject to the terms, provisions and conditions of the Plan and Plan grant agreement. The lifting of restrictions and forfeiture provisions are dependent upon continued service by the grantee until January 1, 2018, except as described in the Plan and the Plan grant agreement. If the service of the grantee ends at the annual shareholder meeting, the stock unit award will vest at such time and will be prorated based upon the number of days served. F2 · derivative.expiration_date: The grantee will be paid for each stock unit, in cash, the value of one share of Vectren's common stock on the date restrictions lapse, provided grantee is in compliance with the share ownership guidelines established by the company. If the grantee is not then in compliance with the company's share ownership guidelines, the value of each stock unit will be paid to the grantee in one unrestricted share of Vectren's common stock. This acquisition was approved in accordance with Rule 16b-3. Read SEC document
January 01, 2017 Filed Jan 4, 2017 11:22 UTC	VECTREN CORP VVC · Entity 160701	GrantPhantom Stock · Derivative	2,144	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001562180-17-000107 · primarydocument.xml · derivative · entry 2 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,016.3883 Underlying: Common Stock · 2,144 shares Expires not disclosed F2 · kind: The reporting person elected to defer the stock unit award to the phantom stock account of the Vectren Corporation Nonqualified Deferred Compensation Plan. This transaction is exempt under Section 16b-3. F3 · derivative.exercise_date: Phantom stock units held under the non-qualified deferred compensation plan will effectively be exercised at the time amounts represented by those units are paid out under the Plan. Generally, unless provided otherwise by the participant, the payout begins with the end of the board member's service as a member of the board. Pursuant to the non-qualified deferred compensation plan, payouts can occur for up to 15 years. Amounts held in the phantom stock accounts would be amortized over that period unless directed otherwise by the participant. F3 · derivative.expiration_date: Phantom stock units held under the non-qualified deferred compensation plan will effectively be exercised at the time amounts represented by those units are paid out under the Plan. Generally, unless provided otherwise by the participant, the payout begins with the end of the board member's service as a member of the board. Pursuant to the non-qualified deferred compensation plan, payouts can occur for up to 15 years. Amounts held in the phantom stock accounts would be amortized over that period unless directed otherwise by the participant. Read SEC document
January 01, 2017 Filed Jan 4, 2017 11:22 UTC	VECTREN CORP VVC · Entity 160701	Exercise / conversionPhantom Stock · Derivative	2,144	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001562180-17-000107 · primarydocument.xml · derivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,144 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock unit award was granted pursuant to the Vectren Corporation At Risk Compensation Plan (Plan) and was subject to the terms, provisions and conditions of the Plan and Plan grant agreement. The lifting of restrictions and forfeiture provisions were dependent upon continued service by the grantee until January 1, 2017, except as described in the Plan and the Plan grant agreement. The grantee was paid for each stock unit, in cash, the value of one share of Vectren's common stock on the date restrictions lapsed. The conditions associated with the award have been fulfilled and it has now been settled. This transaction was approved in accordance with Rule 16b-3. F1 · derivative.expiration_date: The stock unit award was granted pursuant to the Vectren Corporation At Risk Compensation Plan (Plan) and was subject to the terms, provisions and conditions of the Plan and Plan grant agreement. The lifting of restrictions and forfeiture provisions were dependent upon continued service by the grantee until January 1, 2017, except as described in the Plan and the Plan grant agreement. The grantee was paid for each stock unit, in cash, the value of one share of Vectren's common stock on the date restrictions lapsed. The conditions associated with the award have been fulfilled and it has now been settled. This transaction was approved in accordance with Rule 16b-3. Read SEC document
December 01, 2016 Filed Dec 1, 2016 19:07 UTC	Envision Healthcare Holdings, Inc. EVHC · Entity 180702	Disposition to issuerCommon Stock	27,689	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-16-152790 · doc4.xml · nonDerivative · entry 2 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 F1 · kind: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F3 · shares: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each share of common stock held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). F3 · price: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each share of common stock held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). F4 · ownership.direct: These shares of common stock are held in the Michael L. Smith 2013 GRAT I. Read SEC document
December 01, 2016 Filed Dec 1, 2016 19:07 UTC	Envision Healthcare Holdings, Inc. EVHC · Entity 180702	Disposition to issuerCommon Stock	29,506	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-16-152790 · doc4.xml · nonDerivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F2 · shares: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each deferred stock unit held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst deferred stock unit having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). F2 · price: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each deferred stock unit held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst deferred stock unit having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). Read SEC document
December 01, 2016 Filed Dec 2, 2016 16:59 UTC	Envision Healthcare Corp EVHC · Entity 162981	GrantCommon Stock	9,249	Not disclosed	Not disclosed	Disclosure SEC source: 0001678531-16-000070 · wf-form4_148071596513962.xml · nonDerivative · entry 2 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 9,249 F1 · price: Acquisition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., Envision Healthcare Corporation (formerly known as New Amethyst Corp.) (the "Company") and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F2 · price: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time (as defined in the Merger Agreement), each share of Envision Healthcare Holdings, Inc. common stock held by the reporting person immediately prior to the Merger 2 Effective Time was assumed by the Company and converted into 0.334 shares of the Company's common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). F3 · price: Pursuant to the Merger Agreement, equity-based awards granted pursuant to Envision Healthcare Holdings plans that were outstanding immediately prior to the effective time of the Mergers were converted into corresponding awards in respect of the Company's common stock at the effective time of the Mergers, subject to the same terms and conditions (including applicable vesting requirements) as were applicable to such awards prior to the consummation of the Mergers; provided, that equity-based awards granted pursuant to Envision Healthcare Holdings plans were adjusted to reflect the Exchange Ratio (as defined in the Merger Agreement). Read SEC document
December 01, 2016 Filed Dec 2, 2016 16:59 UTC	Envision Healthcare Corp EVHC · Entity 162981	GrantCommon Stock	9,856	Not disclosed	Not disclosed	Disclosure SEC source: 0001678531-16-000070 · wf-form4_148071596513962.xml · nonDerivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,856 F1 · price: Acquisition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., Envision Healthcare Corporation (formerly known as New Amethyst Corp.) (the "Company") and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F2 · price: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time (as defined in the Merger Agreement), each share of Envision Healthcare Holdings, Inc. common stock held by the reporting person immediately prior to the Merger 2 Effective Time was assumed by the Company and converted into 0.334 shares of the Company's common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). F3 · price: Pursuant to the Merger Agreement, equity-based awards granted pursuant to Envision Healthcare Holdings plans that were outstanding immediately prior to the effective time of the Mergers were converted into corresponding awards in respect of the Company's common stock at the effective time of the Mergers, subject to the same terms and conditions (including applicable vesting requirements) as were applicable to such awards prior to the consummation of the Mergers; provided, that equity-based awards granted pursuant to Envision Healthcare Holdings plans were adjusted to reflect the Exchange Ratio (as defined in the Merger Agreement). Read SEC document
February 25, 2016 Filed Sep 28, 2016 12:09 UTC	VECTREN CORP VVC · Entity 160701	GiftCommon Stock	1,082	$0.00	$0.00	Disclosure SEC source: 0001562180-16-003163 · primarydocument.xml · nonDerivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,184 F1 · kind: A "bona fide" gift of securities to charitable organizations is exempt under Section 16(b) by virtue of Rule 16(b)-5. F2 · balance_after: Amount of securities beneficially owned reflects an increase of 121.913 shares made to reconcile Mr. Smith's outstanding share balance. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.